Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,142,000 | 1,343,000 | 1,638,000 | 1,430,000 | 1,043,000 |
| Marketable Securities | 12,454,000 | 13,641,000 | 11,611,000 | 15,887,000 | 19,434,000 |
| Receivables | 11,874,000 | 14,260,000 | 12,078,000 | 11,845,000 | 11,463,000 |
| Inventories | 10,654,000 | 11,468,000 | 11,669,000 | 10,852,000 | 10,851,000 |
| Other current assets | 6,774,000 | 6,212,000 | 6,707,000 | 5,847,000 | 7,567,000 |
| TOTAL | $42,898,000 | $46,924,000 | $43,703,000 | $45,861,000 | $50,358,000 |
| Non-Current Assets | |||||
| PPE Net | 19,317,000 | 18,880,000 | 18,776,000 | 18,347,000 | 18,393,000 |
| Investments And Advances | 1,621,000 | 2,137,000 | 2,120,000 | 2,013,000 | 2,228,000 |
| Intangibles | 124,995,000 | 120,425,000 | 121,699,000 | 122,420,000 | 123,938,000 |
| Other Non-Current Assets | 19,330,000 | 20,365,000 | 19,798,000 | 19,387,000 | 18,479,000 |
| TOTAL | $165,263,000 | $161,807,000 | $162,393,000 | $162,167,000 | $163,038,000 |
| Total Assets | $208,160,000 | $208,731,000 | $206,095,000 | $208,028,000 | $213,396,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,154,000 | 4,303,000 | 4,295,000 | 4,470,000 | 6,946,000 |
| Accounts payable and accrued liabilities | 5,240,000 | 5,024,000 | 5,166,000 | 5,240,000 | 5,633,000 |
| Accrued Expenses | 3,610,000 | 3,036,000 | 2,447,000 | 2,607,000 | 3,838,000 |
| Other current liabilities | 18,648,000 | 19,509,000 | 18,575,000 | 20,016,000 | 19,720,000 |
| TOTAL | $36,984,000 | $36,596,000 | $37,726,000 | $36,452,000 | $42,995,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,641,000 | 57,409,000 | 57,502,000 | 57,639,000 | 57,405,000 |
| Deferred Revenues | 784,000 | 924,000 | 1,123,000 | 1,012,000 | 1,511,000 |
| Other Non-Current Liabilities | 20,349,000 | 19,154,000 | 19,356,000 | 21,036,000 | 22,369,000 |
| TOTAL | $84,399,000 | $79,039,000 | $79,357,000 | $80,939,000 | $81,904,000 |
| Total Liabilities | $121,385,000 | $115,635,000 | $117,083,000 | $117,391,000 | $124,899,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,686,267 | 5,685,708 | 5,685,551 | 5,685,366 | 5,667,340 |
| Common Shares | 481,000 | 481,000 | 481,000 | 481,000 | 480,000 |
| Retained earnings | 114,610,000 | 121,150,000 | 117,609,000 | 119,590,000 | 116,725,000 |
| Other shareholders' equity | -7,770,000 | -7,772,000 | -8,121,000 | -8,282,000 | -7,548,000 |
| TOTAL | $86,775,000 | $93,096,000 | $89,012,000 | $90,637,000 | $88,497,000 |
| Total Liabilities And Equity | $208,160,000 | $208,731,000 | $206,095,000 | $208,028,000 | $213,396,000 |